LobbyingAmerican Association of Child & Adolescent Psychiatry lobbying by quarter
American Association of Child & Adolescent Psychiatry's latest lobbying report covers Q2 2026, at $30K. The four quarters Q4 2025–Q3 2026 total $180K. Its first report covers Q2 2021; the issues it reports most are Health Issues and Budget/Appropriations.
American Association of Child & Adolescent Psychiatry
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $180K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q2 2021
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2021 | $20K | 1 |
| Q3 2021 | $20K | 1 |
| Q4 2021 | $45K | 1 |
| Q1 2022 | $45K | 1 |
| Q2 2022 | $47K | 1 |
| Q3 2022 | $48K | 1 |
| Q4 2022 | $48K | 1 |
| Q1 2023 | $75K | 1 |
| Q2 2023 | $75K | 1 |
| Q3 2023 | $75K | 1 |
| Q4 2023 | $75K | 1 |
| Q1 2024 | $75K | 1 |
| Q2 2024 | $75K | 1 |
| Q3 2024 | $75K | 1 |
| Q4 2024 | $75K | 1 |
| Q1 2025 | $75K | 1 |
| Q2 2025 | $75K | 1 |
| Q3 2025 | $75K | 1 |
| Q4 2025 | $75K | 1 |
| Q1 2026 | $75K | 1 |
| Q2 2026 | $30K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$916.5K · 20 reports
- Budget and appropriations$316.5K · 11 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES20 reports
- SENATE20 reports
- Substance Abuse & Mental Health Services Administration (SAMHSA)3 reports
- Centers For Medicare and Medicaid Services (CMS)2 reports
- Executive Office of the President (EOP)2 reports
- Health & Human Services, Dept of (HHS)2 reports
- White House Office2 reports
- Homeland Security, Dept of (DHS)1 reports
- Labor, Dept of (DOL)1 reports
- State, Dept of (DOS)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseAmerican Association of Child & Adolescent Psychiatry | $1.3M | 21 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | In-house | $30K |
| 04/20for Q1 | In-house | $75K |
| 01/16for Q4 2025 | In-house | $75K |
| 25/10/03for Q3 2025 | In-house | $75K |
| 25/07/21for Q2 2025 | In-house | $75K |
| 25/04/25for Q1 2025 | In-house | $75K |
| 25/01/28for Q4 2024 | In-house | $75K |
| 24/10/24for Q3 2024 | In-house | $75K |
| 24/07/18for Q2 2024 | In-house | $75K |
| 24/04/22for Q1 2024 | In-house | $75K |
| 24/01/19for Q4 2023 | In-house | $75K |
| 23/10/20for Q3 2023 | In-house | $75K |
| 23/07/21for Q2 2023 | In-house | $75K |
| 23/04/17for Q1 2023 | In-house | $75K |
| 23/01/30for Q4 2022 | In-house | $48K |
| 23/01/30for Q3 2022 | In-house | $48K |
| 23/01/30for Q2 2022 | In-house | $47K |
| 23/01/30for Q1 2022 | In-house | $45K |
| 23/01/30for Q4 2021 | In-house | $45K |
| 23/01/30for Q3 2021 | In-house | $20K |